HEADER OXIDOREDUCTASE 16-MAR-06 2CI0 TITLE HIGH THROUGHPUT SCREENING AND X-RAY CRYSTALLOGRAPHY ASSISTED TITLE 2 EVALUATION OF SMALL MOLECULE SCAFFOLDS FOR CYP51 INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYTOCHROME P450 51; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: STEROL 14ALPHA-DEMETHYLASE CYP51, YPLI, P450-LIA1, STEROL COMPND 5 14-ALPHA DEMETHYLASE, LANOSTEROL 14-ALPHA DEMETHYLASE, P450-14DM; COMPND 6 EC: 1.14.13.70; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 OTHER_DETAILS: 4XHIS TAG AT THE C-TERMINUS SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 3 ORGANISM_TAXID: 83332; SOURCE 4 STRAIN: H37RV; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: HMS174(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PET; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET17B KEYWDS HEME, HEME LIPID SYNTHESIS, METAL-BINDING, MONOOXYGENASE, NADP, KEYWDS 2 OXIDOREDUCTASE, PROTEIN-INHIBITOR COMPLEX, STEROID BIOSYNTHESIS, KEYWDS 3 STEROL BIOSYNTHESIS EXPDTA X-RAY DIFFRACTION AUTHOR L.M.PODUST,Y.KIM,L.V.YERMALITSKAYA,J.P.VON KRIES,M.R.WATERMAN REVDAT 5 13-DEC-23 2CI0 1 LINK REVDAT 4 24-FEB-09 2CI0 1 VERSN REVDAT 3 30-OCT-07 2CI0 1 JRNL REVDAT 2 04-SEP-07 2CI0 1 JRNL HELIX REVDAT 1 03-JUL-07 2CI0 0 JRNL AUTH L.M.PODUST,J.P.VON KRIES,A.N.EDDINE,Y.KIM,L.V.YERMALITSKAYA, JRNL AUTH 2 R.KUEHNE,H.OUELLET,T.WARRIER,M.ALTEKOSTER,J.-S.LEE, JRNL AUTH 3 J.RADEMANN,H.OSCHKINAT,S.H.E.KAUFMANN,M.R.WATERMAN JRNL TITL SMALL MOLECULE SCAFFOLDS FOR CYP51 INHIBITORS IDENTIFIED BY JRNL TITL 2 HIGH THROUGHPUT SCREENING AND DEFINED BY X-RAY JRNL TITL 3 CRYSTALLOGRAPHY JRNL REF ANTIMICROB.AGENTS CHEMOTHER. V. 51 3915 2007 JRNL REFN ISSN 0066-4804 JRNL PMID 17846131 JRNL DOI 10.1128/AAC.00311-07 REMARK 2 REMARK 2 RESOLUTION. 1.53 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.53 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.42 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 322653.730 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.4 REMARK 3 NUMBER OF REFLECTIONS : 62309 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT : 6286 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.003 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.53 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.63 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 84.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 8176 REMARK 3 BIN R VALUE (WORKING SET) : 0.2380 REMARK 3 BIN FREE R VALUE : 0.2610 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 887 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.009 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3305 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 61 REMARK 3 SOLVENT ATOMS : 364 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 11.74000 REMARK 3 B22 (A**2) : -4.19000 REMARK 3 B33 (A**2) : -7.55000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.18 REMARK 3 ESD FROM SIGMAA (A) : 0.13 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.14 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.890 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.100 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.690 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.970 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.950 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.38 REMARK 3 BSOL : 55.31 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER_REP.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: DISORDERED REGIONS DISORDERED REGIONS REMARK 3 WERE OMMITED FROM THE STRUCTURE REMARK 4 REMARK 4 2CI0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-MAR-06. REMARK 100 THE DEPOSITION ID IS D_1290028200. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-FEB-06 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00931 REMARK 200 MONOCHROMATOR : SI (220) DOUBLE CRYSTAL REMARK 200 OPTICS : SAGITTAL FOCUSING CRYSTAL AND REMARK 200 VERTICALLY FOCUSING DOUBLE MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 65111 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.530 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : 0.04000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 47.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.53 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.58 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 0.14000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 9.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1X8V REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.09 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15 % PEG 4000,1% ISOPROPANOL, 0.1 M REMARK 280 HEPES, PH=7.5; 2 MM (2R)-2-PHENYL-N-PYRIDIN-4- YLBUTANAMIDE, PH REMARK 280 7.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.49850 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.26000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.77550 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 55.26000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.49850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.77550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, CYS 37 TO LEU REMARK 400 ENGINEERED RESIDUE IN CHAIN A, CYS 442 TO ALA REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 GLU A 85 REMARK 465 GLY A 86 REMARK 465 VAL A 87 REMARK 465 VAL A 88 REMARK 465 PHE A 89 REMARK 465 ASP A 90 REMARK 465 ALA A 91 REMARK 465 SER A 92 REMARK 465 PRO A 93 REMARK 465 GLU A 94 REMARK 465 ARG A 95 REMARK 465 ARG A 96 REMARK 465 LYS A 97 REMARK 465 GLU A 98 REMARK 465 MET A 99 REMARK 465 LEU A 100 REMARK 465 HIS A 101 REMARK 465 ASN A 102 REMARK 465 ALA A 103 REMARK 465 ALA A 104 REMARK 465 PRO A 217 REMARK 465 THR A 218 REMARK 465 ASP A 219 REMARK 465 LYS A 220 REMARK 465 SER A 221 REMARK 465 GLY A 450 REMARK 465 VAL A 451 REMARK 465 HIS A 452 REMARK 465 HIS A 453 REMARK 465 HIS A 454 REMARK 465 HIS A 455 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 67 CG OD1 OD2 REMARK 470 ASP A 68 CG OD1 OD2 REMARK 470 GLN A 72 CG CD OE1 NE2 REMARK 470 ARG A 106 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 108 CG CD OE1 OE2 REMARK 470 GLN A 109 CG CD OE1 NE2 REMARK 470 ASP A 222 CG OD1 OD2 REMARK 470 GLU A 235 CG CD OE1 OE2 REMARK 470 THR A 236 OG1 CG2 REMARK 470 GLU A 331 CG CD OE1 OE2 REMARK 470 GLU A 333 CG CD OE1 OE2 REMARK 470 GLN A 372 CG CD OE1 NE2 REMARK 470 ARG A 391 CG CD NE CZ NH1 NH2 REMARK 470 THR A 449 CA C O CB OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 MET A 225 CG MET A 225 SD -0.172 REMARK 500 MET A 225 CG MET A 225 SD -0.190 REMARK 500 MET A 225 SD MET A 225 CE 0.669 REMARK 500 MET A 225 SD MET A 225 CE 1.817 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 MET A 225 CG - SD - CE ANGL. DEV. = -18.0 DEGREES REMARK 500 MET A 225 CG - SD - CE ANGL. DEV. = -52.8 DEGREES REMARK 500 ARG A 413 CG - CD - NE ANGL. DEV. = -13.3 DEGREES REMARK 500 ARG A 413 CG - CD - NE ANGL. DEV. = -14.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 25 70.51 -150.11 REMARK 500 ALA A 46 -122.78 61.13 REMARK 500 ASP A 183 126.99 -170.07 REMARK 500 ASP A 224 -168.48 -127.67 REMARK 500 ASP A 224 -169.03 -127.67 REMARK 500 GLN A 375 54.67 36.25 REMARK 500 ASN A 380 65.07 -102.12 REMARK 500 ALA A 441 59.95 -148.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2062 DISTANCE = 5.93 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A1449 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 394 SG REMARK 620 2 HEM A1449 NA 94.0 REMARK 620 3 HEM A1449 NB 84.7 89.9 REMARK 620 4 HEM A1449 NC 85.8 179.7 90.3 REMARK 620 5 HEM A1449 ND 94.1 90.0 178.8 89.8 REMARK 620 6 1CM A1450 N11 173.6 87.7 89.1 92.5 92.1 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A1449 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1CM A1450 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1E9X RELATED DB: PDB REMARK 900 CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE ( CYP51) FROM REMARK 900 MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH 4-PHENYLIMIDAZOLE REMARK 900 RELATED ID: 1EA1 RELATED DB: PDB REMARK 900 CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE ( CYP51) FROM REMARK 900 MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH FLUCONAZOLE REMARK 900 RELATED ID: 1H5Z RELATED DB: PDB REMARK 900 CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE ( CYP51) FROM REMARK 900 MYCOBACTERIUM TUBERCULOSIS IN FERRIC LOW-SPIN STATE REMARK 900 RELATED ID: 1U13 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF THE C37L/C151T /C442A-TRIPLEMUTANT OF REMARK 900 CYP51 FROM MYCOBACTERIUM TUBERCULOSIS REMARK 900 RELATED ID: 1X8V RELATED DB: PDB REMARK 900 ESTRIOL-BOUND AND LIGAND-FREE STRUCTURES OF STEROL 14ALPHA- REMARK 900 DEMETHYLASE (CYP51) REMARK 900 RELATED ID: 2BZ9 RELATED DB: PDB REMARK 900 LIGAND-FREE STRUCTURE OF STEROL 14ALPHA- DEMETHYLASE FROM REMARK 900 MYCOBACTERIUM TUBERCULOSIS IN P2(1) SPACE GROUP REMARK 900 RELATED ID: 2CIB RELATED DB: PDB REMARK 900 HIGH THROUGHPUT SCREENING AND X-RAY CRYSTALLOGRAPHY ASSISTED REMARK 900 EVALUATION OF SMALL MOLECULE SCAFFOLDS FOR CYP51 INHIBITORS REMARK 999 REMARK 999 SEQUENCE REMARK 999 MUTATIONS C37L, C442A 4XHIS TAG AT THE C-TERMINUS DBREF 2CI0 A 1 451 UNP P0A512 CP51_MYCTU 1 451 DBREF 2CI0 A 452 455 PDB 2CI0 2CI0 452 455 SEQADV 2CI0 LEU A 37 UNP P0A512 CYS 37 ENGINEERED MUTATION SEQADV 2CI0 ALA A 442 UNP P0A512 CYS 442 ENGINEERED MUTATION SEQRES 1 A 455 MET SER ALA VAL ALA LEU PRO ARG VAL SER GLY GLY HIS SEQRES 2 A 455 ASP GLU HIS GLY HIS LEU GLU GLU PHE ARG THR ASP PRO SEQRES 3 A 455 ILE GLY LEU MET GLN ARG VAL ARG ASP GLU LEU GLY ASP SEQRES 4 A 455 VAL GLY THR PHE GLN LEU ALA GLY LYS GLN VAL VAL LEU SEQRES 5 A 455 LEU SER GLY SER HIS ALA ASN GLU PHE PHE PHE ARG ALA SEQRES 6 A 455 GLY ASP ASP ASP LEU ASP GLN ALA LYS ALA TYR PRO PHE SEQRES 7 A 455 MET THR PRO ILE PHE GLY GLU GLY VAL VAL PHE ASP ALA SEQRES 8 A 455 SER PRO GLU ARG ARG LYS GLU MET LEU HIS ASN ALA ALA SEQRES 9 A 455 LEU ARG GLY GLU GLN MET LYS GLY HIS ALA ALA THR ILE SEQRES 10 A 455 GLU ASP GLN VAL ARG ARG MET ILE ALA ASP TRP GLY GLU SEQRES 11 A 455 ALA GLY GLU ILE ASP LEU LEU ASP PHE PHE ALA GLU LEU SEQRES 12 A 455 THR ILE TYR THR SER SER ALA CYS LEU ILE GLY LYS LYS SEQRES 13 A 455 PHE ARG ASP GLN LEU ASP GLY ARG PHE ALA LYS LEU TYR SEQRES 14 A 455 HIS GLU LEU GLU ARG GLY THR ASP PRO LEU ALA TYR VAL SEQRES 15 A 455 ASP PRO TYR LEU PRO ILE GLU SER PHE ARG ARG ARG ASP SEQRES 16 A 455 GLU ALA ARG ASN GLY LEU VAL ALA LEU VAL ALA ASP ILE SEQRES 17 A 455 MET ASN GLY ARG ILE ALA ASN PRO PRO THR ASP LYS SER SEQRES 18 A 455 ASP ARG ASP MET LEU ASP VAL LEU ILE ALA VAL LYS ALA SEQRES 19 A 455 GLU THR GLY THR PRO ARG PHE SER ALA ASP GLU ILE THR SEQRES 20 A 455 GLY MET PHE ILE SER MET MET PHE ALA GLY HIS HIS THR SEQRES 21 A 455 SER SER GLY THR ALA SER TRP THR LEU ILE GLU LEU MET SEQRES 22 A 455 ARG HIS ARG ASP ALA TYR ALA ALA VAL ILE ASP GLU LEU SEQRES 23 A 455 ASP GLU LEU TYR GLY ASP GLY ARG SER VAL SER PHE HIS SEQRES 24 A 455 ALA LEU ARG GLN ILE PRO GLN LEU GLU ASN VAL LEU LYS SEQRES 25 A 455 GLU THR LEU ARG LEU HIS PRO PRO LEU ILE ILE LEU MET SEQRES 26 A 455 ARG VAL ALA LYS GLY GLU PHE GLU VAL GLN GLY HIS ARG SEQRES 27 A 455 ILE HIS GLU GLY ASP LEU VAL ALA ALA SER PRO ALA ILE SEQRES 28 A 455 SER ASN ARG ILE PRO GLU ASP PHE PRO ASP PRO HIS ASP SEQRES 29 A 455 PHE VAL PRO ALA ARG TYR GLU GLN PRO ARG GLN GLU ASP SEQRES 30 A 455 LEU LEU ASN ARG TRP THR TRP ILE PRO PHE GLY ALA GLY SEQRES 31 A 455 ARG HIS ARG CYS VAL GLY ALA ALA PHE ALA ILE MET GLN SEQRES 32 A 455 ILE LYS ALA ILE PHE SER VAL LEU LEU ARG GLU TYR GLU SEQRES 33 A 455 PHE GLU MET ALA GLN PRO PRO GLU SER TYR ARG ASN ASP SEQRES 34 A 455 HIS SER LYS MET VAL VAL GLN LEU ALA GLN PRO ALA ALA SEQRES 35 A 455 VAL ARG TYR ARG ARG ARG THR GLY VAL HIS HIS HIS HIS HET HEM A1449 47 HET 1CM A1450 18 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM 1CM (2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE HETSYN HEM HEME FORMUL 2 HEM C34 H32 FE N4 O4 FORMUL 3 1CM C15 H16 N2 O FORMUL 4 HOH *364(H2 O) HELIX 1 1 HIS A 18 ARG A 23 1 6 HELIX 2 2 ASP A 25 GLY A 38 1 14 HELIX 3 3 SER A 54 ALA A 65 1 12 HELIX 4 4 TYR A 76 PHE A 78 5 3 HELIX 5 5 MET A 79 GLY A 84 1 6 HELIX 6 6 ARG A 106 ALA A 126 1 21 HELIX 7 7 LEU A 136 ILE A 153 1 18 HELIX 8 8 GLY A 154 ASP A 159 1 6 HELIX 9 9 ASP A 162 ARG A 174 1 13 HELIX 10 10 ASP A 177 VAL A 182 5 6 HELIX 11 11 ILE A 188 ASN A 215 1 28 HELIX 12 12 ASP A 224 VAL A 232 1 9 HELIX 13 13 SER A 242 HIS A 275 1 34 HELIX 14 14 HIS A 275 TYR A 290 1 16 HELIX 15 15 GLY A 291 GLY A 293 5 3 HELIX 16 16 SER A 295 ALA A 300 1 6 HELIX 17 17 ILE A 304 HIS A 318 1 15 HELIX 18 18 SER A 348 ASN A 353 1 6 HELIX 19 19 VAL A 366 GLU A 371 5 6 HELIX 20 20 GLN A 375 ASN A 380 1 6 HELIX 21 21 ALA A 389 ARG A 393 5 5 HELIX 22 22 GLY A 396 GLU A 414 1 19 HELIX 23 23 PRO A 422 TYR A 426 5 5 SHEET 1 AA 5 VAL A 40 LEU A 45 0 SHEET 2 AA 5 LYS A 48 LEU A 53 -1 O LYS A 48 N LEU A 45 SHEET 3 AA 5 LEU A 344 ALA A 347 1 O LEU A 344 N VAL A 51 SHEET 4 AA 5 LEU A 324 ALA A 328 -1 O LEU A 324 N ALA A 347 SHEET 5 AA 5 LEU A 70 ASP A 71 -1 O ASP A 71 N VAL A 327 SHEET 1 AB 3 ALA A 131 ASP A 135 0 SHEET 2 AB 3 ALA A 442 ARG A 447 -1 O VAL A 443 N ILE A 134 SHEET 3 AB 3 TYR A 415 MET A 419 -1 O GLU A 416 N ARG A 446 SHEET 1 AC 2 PHE A 332 VAL A 334 0 SHEET 2 AC 2 HIS A 337 ILE A 339 -1 O HIS A 337 N VAL A 334 SHEET 1 AD 2 ASN A 428 ASP A 429 0 SHEET 2 AD 2 GLN A 436 LEU A 437 -1 O GLN A 436 N ASP A 429 LINK SG CYS A 394 FE HEM A1449 1555 1555 2.53 LINK FE HEM A1449 N11 1CM A1450 1555 1555 2.68 CISPEP 1 GLN A 439 PRO A 440 0 0.25 SITE 1 AC1 17 LEU A 105 GLY A 257 THR A 260 THR A 264 SITE 2 AC1 17 ARG A 326 PRO A 386 PHE A 387 GLY A 388 SITE 3 AC1 17 ARG A 391 HIS A 392 ARG A 393 CYS A 394 SITE 4 AC1 17 VAL A 395 1CM A1450 HOH A2072 HOH A2362 SITE 5 AC1 17 HOH A2363 SITE 1 AC2 8 TYR A 76 MET A 79 ALA A 256 THR A 260 SITE 2 AC2 8 LEU A 321 MET A 433 HEM A1449 HOH A2209 CRYST1 44.997 85.551 110.520 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022224 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011689 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009048 0.00000